• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Galderma

Galderma Nemluvio
Manufacturing

Galderma plans to spend $650M on US-based manufacturing

Galderma has hopped on the U.S. manufacturing bandwagon, revealing a plan to spend more than $650 million through 2030 in the U.S.
Kevin Dunleavy Oct 23, 2025 11:18am
Galderma Nemluvio

Galderma's itch relief claims scratched after Sanofi complaint

Oct 8, 2025 9:45am
A photo from Galdermas Scratch Resistance campaign showing a woman standing at the top of a pile of rulers

Galderma starts DTC campaign for eczema drug across TV, digital

Apr 22, 2025 10:55am
Eczema

Organon's Vtama, Galderma's Nemluvio endorsed by FDA for eczema

Dec 16, 2024 9:00am
Traffic light go start restart green light

FDA approves Galderma's prurigo nodularis treatment Nemluvio

Aug 13, 2024 10:37am
IPO initial public offering Wall Street

Galderma kicks off the process for $2.6B IPO

Mar 13, 2024 12:17pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings